Abstract:BACKGROUND/AIMS:The long non-coding RNA colorectal neoplasia differentially expressed (CRNDE) contributes to the proliferation and migration of tumors. However, its molecular mechanism underlying gastric cancer remains unknown. In the present study, we investigated whether CRNDE was involved in the development of colorectal cancer via the binding of microRNA (miR)-217 with transcription factor 7-like 2 (TCF7L2) to enhance the Wnt signaling pathway.METHODS:Quantitative polymerase chain reaction was used to detect CRNDE, miR-217 and TCF7L2 in colorectal cancer tissues and cells. The CCK-8 assay, wound healing assay, and Transwell assay were used to detect cell proliferation, migration and invasion, respectively. Western blotting and luciferase activity assays were used to identify CRNDE and TCF7L2 as one of the direct targets of miR-217. The activity of the Wnt/β-catenin signaling pathway was analyzed by the TOPflash assay, and the subcellular localization of β-catenin and TCF7L2 was analyzed by western blotting and confocal microscopy.RESULTS:In this study, we found that high expression of CRNDE is negatively correlated with low expression of miR-217 in colorectal cancer tissue and colorectal cancer cells. The dual luciferase reporter analysis showed that miR-217 is bound to CRNDE and TCF7L2 and negatively regulate their expression. CRNDE down-regulation inhibited the cell proliferation, migration and invasion in vitro and in vivo and the inhibitions were both completely blocked after miR-217 inhibition or TCF7L2 overexpression. Finally, TOPflash analysis showed that the activity of Wnt/β-catenin signaling is inhibited by CRNDE down-regulation and rescued by TCF7L2 over-expression. Consistently immunostaining and western blotting analysis showed that the expression of b-catenin and TCF7L2 in the nucleus was significantly decreased by CRNDE down-regulation and was rescued by TCF7L2 over-expression.CONCLUSIONS:The present study suggest that CRNDE involves in the cell proliferation, migration and invasion of colorectal cancer cells via increasing the expression of TCF7L2 and activity of Wnt/β-catenin signaling through binding miR-217 competitively.

Highly expressed long non-coding RNA CRNDE promotes cell proliferation through PI3K/AKT signalling in non-small cell lung carcinoma.

Highly Expressed Lncrna CRNDE Promotes Cell Proliferation Through Wnt/β-catenin Signaling in Renal Cell Carcinoma

Long noncoding RNA CRNDE stabilized by hnRNPUL2 accelerates cell proliferation and migration in colorectal carcinoma via activating Ras/MAPK signaling pathways

LncRNA CRNDE is a biomarker for clinical progression and poor prognosis in clear cell renal cell carcinoma.

Comprehensive Analysis of the Prognostic Value and Molecular Function of CRNDE in Glioma at Bulk and Single-Cell Levels

Long noncoding RNA CRNDE promotes colorectal cancer cell proliferation via epigenetically silencing DUSP5/CDKN1A expression

Long Non-Coding RNA CRNDE Promotes Malignant Progression of Hepatocellular Carcinoma Through the Mir-33A-5p/cdk6 Axis

LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression

The long non-coding RNA CRNDE acts as a ceRNA and promotes glioma malignancy by preventing miR-136-5p-mediated downregulation of Bcl-2 and Wnt2.

Overexpression of CRNDE promotes the progression of bladder cancer

The long non-coding RNA CRNDE acts as a ceRNA and promotes glioma malignancy by preventing miR-1365 p-mediated downregulation of Bcl-2 and Wnt 2

The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling

LncRNA CRNDE is Activated by SP1 and Promotes Osteosarcoma Proliferation, Invasion, and Epithelial‐mesenchymal Transition Via Wnt/β‐catenin Signaling Pathway

Long Non-Coding Rna Crnde Promotes Tumor Growth in Medulloblastoma

Long Non-Coding RNA CRNDE Enhances Cervical Cancer Progression by Suppressing PUMA Expression

CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186

LncRNA CRNDE Drives the Progression of Hepatocellular Carcinoma by inducing the Immunosuppressive Niche

Long Noncoding RNA CRNDE Functions as an Oncogene to Facilitate Aggressive Behaviors of Nasopharyngeal Carcinoma Cells by Modulating miR-3163/TWIST1 Axis

The Long Non-Coding RNA CRNDE Promotes Colorectal Carcinoma Progression by Competitively Binding Mir-217 with TCF7L2 and Enhancing the Wnt/β-Catenin Signaling Pathway.

CRNDE: A Valuable Long Noncoding RNA for Diagnosis and Therapy of Solid and Hematological Malignancies

Long Non-Coding RNA BC087858 Induces Non-T790m Mutation Acquired Resistance to EGFR-TKIs by Activating PI3K/AKT and MEK/ERK Pathways and EMT in Non-Small-cell Lung Cancer